Single-dose and Multiple-dose X842 Phase 1 Study

NCT04293965 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jiangsu Sinorda Biomedicine Co., Ltd